Inducible expression of indoleamine 2,3-dioxygenase attenuates acute rejection of tissue-engineered lung allografts in rats

Gene

Volumn 576, Issue 1, 2016, Pages 412-420

  Ebrahimi, Ammar ^a   Kardar, Gholam Ali ^a   Toolabi, LadanTeimoori ^b   Ghanbari, Hossein ^a   Sadroddiny, Esmaeil ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Engineered lung; Immunosuppression; Indoleamine 2,3 dioxygenase; Lung transplantation

Indexed keywords

GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; MESSENGER RNA; RANTES; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT REJECTION; ADULT; ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD3+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE TRANSFER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LUNG ALLOGRAFT; LUNG GRAFT REJECTION; LUNG PARENCHYMA; LUNG TRANSPLANTATION; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE ENGINEERING; UPREGULATION; ANIMAL; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; GRAFT REJECTION; STEM CELL; WISTAR RAT;

ANIMALS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GRAFT REJECTION; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; LUNG TRANSPLANTATION; MALE; RATS; RATS, WISTAR; STEM CELLS; TISSUE ENGINEERING;

EID: 84949625055     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.10.054     Document Type: Article

References (27)

1. Orens J.B., Garrity E.R. General overview of lung transplantation and review of organ allocation. Proc. Am. Thorac. Soc. 2009, 6:13-19.
2. Andrade C.F., Wong A.P., Waddell T.K., Keshavjee S., Liu M. Cell-based tissue engineering for lung regeneration. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 292:L510-L518.
3. Ott H.C., Clippinger B., Conrad C., Schuetz C., Pomerantseva I., Ikonomou L., et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat. Med. 2010, 16:927-933.
4. Cortiella J., Niles J., Cantu A., Brettler A., Pham A., Vargas G., et al. Influence of acellular natural lung matrix on murine embryonic stem cell differentiation and tissue formation. Tissue Eng. A 2010, 16:2565-2580.
5. Buell J.F., Gross T.G., Woodle E.S. Malignancy after transplantation. Transplantation 2005, 80:S254-S64.
6. Minari A., Husni R., Avery R., Longworth D., DeCamp M., Bertin M., et al. The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants. Transpl. Infect. Dis. 2002, 4:195-200.
7. Rahim F., Ebrahimi A. Gene therapy modalities in lung transplantation. Transpl. Immunol. 2014, 31:165-172.
8. Muller A.J., Prendergast G.C. Indoleamine 2,3-dioxygenase in immune suppression and cancer. Curr. Cancer Drug Targets 2007, 7:31-40.
9. Yu G., Dai H., Chen J., Duan L., Gong M., Liu L., et al. Gene delivery of indoleamine 2,3-dioxygenase prolongs cardiac allograft survival by shaping the types of T-cell responses. J. Gene Med. 2008, 10:754-761.
10. Vavrincova-Yaghi D., Deelman L.E., Goor H., Seelen M., Kema I.P., Smit-van Oosten A., et al. Gene therapy with adenovirus-delivered indoleamine 2,3-dioxygenase improves renal function and morphology following allogeneic kidney transplantation in rat. J. Gene Med. 2011, 13:373-381.
11. Liu H., Liu L., Fletcher B.S., Visner G.A. Novel action of indoleamine 2, 3-dioxygenase attenuating acute lung allograft injury. Am. J. Respir. Crit. Care Med. 2006, 173:566-572.
12. Petersen T.H., Calle E.A., Zhao L., Lee E.J., Gui L., Raredon M.B., et al. Tissue-engineered lungs for in vivo implantation. Science 2010, 329:538-541.
13. Abràmoff M.D., Magalhães P.J., Ram S.J. Image processing with ImageJ. Biophoton. Int. 2004, 11:36-42.
14. Kistner A., Gossen M., Zimmermann F., Jerecic J., Ullmer C., Lübbert H., et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl. Acad. Sci. 1996, 93:10933-10938.
15. Alexander A.M., Crawford M., Bertera S., Rudert W.A., Takikawa O., Robbins P.D., et al. Indoleamine 2, 3-dioxygenase expression in transplanted NOD islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes. Diabetes 2002, 51:356-365.
16. Swanson K.A., Zheng Y., Heidler K.M., Mizobuchi T., Wilkes D.S. CDllc+cells modulate pulmonary immune responses by production of indoleamine 2, 3-dioxygenase. Am. J. Respir. Cell Mol. Biol. 2004, 30:311-318.
17. Graca L., Cobbold S.P., Waldmann H. Identification of regulatory T cells in tolerated allografts. J. Exp. Med. 2002, 195:1641-1646.
18. Curti A., Pandolfi S., Valzasina B., Aluigi M., Isidori A., Ferri E., et al. Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells. Blood 2007, 109:2871-2877.
19. Lin Y.C., Chen C.L., Nakano T., Goto S., Kao Y.H., Hsu L.W., et al. Immunological role of indoleamine 2,3-dioxygenase in rat liver allograft rejection and tolerance. J. Gastroenterol. Hepatol. 2008, 23:e243-e250.
20. Letterio J.J., Roberts A.B. Regulation of immune responses by TGF-β*. Annu. Rev. Immunol. 1998, 16:137-161.
21. Franklin T. Therapeutic approaches to organ fibrosis. Int. J. Biochem. Cell Biol. 1997, 29:79-89.
22. Chan S.Y., Goodman R.E., Szmuszkovicz J.R., Roessler B., Eichwald E.J., Bishop D.K. Dna-liposome versus adenoviral mediated gene transfer of transforming growth factorβ1 in vascularized cardiac allografts: differential sensitivity of CD4+ and CD8+ T cells to transforming growth factorβ11. Transplantation 2000, 70:1292-1301.
23. Jain S., Furness P.N., Nicholson M.L. The role of transforming growth factor beta in chronic renal allograft nephropathy. Transplantation 2000, 69:1759-1766.
24. Liu H., Liu L., Fletcher B.S., Visner G.A. Sleeping beauty-based gene therapy with indoleamine 2,3-dioxygenase inhibits lung allograft fibrosis. FASEB J. 2006, 20:2384-2386.
25. Laurence J.M., Wang C., Zheng M., Cunningham S., Earl J., Tay S.S., et al. Overexpression of indoleamine dioxygenase in rat liver allografts using a high-efficiency adeno-associated virus vector does not prevent acute rejection. Liver Transpl. 2009, 15:233-241.
26. Daly A.B., Wallis J.M., Borg Z.D., Bonvillain R.W., Deng B., Ballif B.A., et al. Initial binding and recellularization of decellularized mouse lung scaffolds with bone marrow-derived mesenchymal stromal cells. Tissue Eng. A 2011, 18:1-16.
27. Bonvillain R.W., Danchuk S., Sullivan D.E., Betancourt A.M., Semon J.A., Eagle M.E., et al. A nonhuman primate model of lung regeneration: detergent-mediated decellularization and initial in vitro recellularization with mesenchymal stem cells. Tissue Eng. A 2012, 18:2437-2452.